Press Releases

Date Title and Summary
Toggle Summary Hong Kong Sanatorium & Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact® System and ClearRT™ Helical Fan-Beam kVCT Imaging
ClearRT Significantly Improves Image Quality, Facilitating the Delivery of More Precise and Accurate Treatments to Patients SUNNYVALE, Calif. , July 22, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at Hong Kong Sanatorium & Hospital  (HKSH) in
Toggle Summary Accuray to Report Fiscal Year-End 2021 Financial Results on August 11, 2021
SUNNYVALE, Calif. , July 14, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) will report financial results for the fourth quarter and fiscal year 2021, ended June 30, 2021 , after the market close on Wednesday, August 11, 2021. Management will host a conference call to review the results
Toggle Summary Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology
- UW-Madison School of Veterinary Medicine performed the first-in-world treatment - Renowned veterinary school leveraged the advanced Radixact and Synchrony technology, currently available at top academic hospitals, to provide the highest level of care SUNNYVALE, Calif.
Toggle Summary Accuray Announces Promotion of Suzanne Winter to President
SUNNYVALE, Calif. , June 22, 2021 /PRNewswire/ --  Accuray (NASDAQ: ARAY) announced today that Suzanne Winter has been promoted to president, effective as of July 1, 2021 . Ms. Winter , who previously served as the company's chief commercial officer and senior vice president of R&D and medical and
Toggle Summary Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System
Treatment Planning for the CyberKnife System and Other Radiation Therapy Devices Can Now be Performed Using the Same Software Solution SUNNYVALE, Calif. , June 16, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the launch of RayStation* treatment planning support for the
Toggle Summary Accuray Expands Commercialization of ClearRT™ Helical Fan-Beam kVCT Imaging for the Radixact® System with CE Mark Certification
Expands Global Access to Exceptional Quality Diagnostic-like CT Images for Medical Care Teams Using the Radixact System SUNNYVALE, Calif. , June 10, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the company has received CE Mark certification for its ClearRT ™ helical
Toggle Summary Accuray Announces New $120 Million Credit Facility
Refinancing Significantly Reduces Interest Rate and Extends Maturity with Increased Operational Flexibility SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced it has entered into a new five-year $80 million term loan and $40 million revolving
Toggle Summary Accuray Announces Convertible Notes Exchange and Subscription
SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced that it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2022 (the "2022 Notes") to exchange an aggregate of $82.1 million
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , May 6, 2021 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Jean-Philippe Pignol , M.D., Ph.D., the company's new Chief Medical & Technology Officer. As a material inducement to Dr.
Toggle Summary Geisinger becomes first in U.S. to treat cancer patients with Accuray Synchrony® technology on the Radixact® and CyberKnife® S7™ Systems to better target radiation treatments
WILKES-BARRE, Pa. and SUNNYVALE, Calif. , May 3, 2021 /PRNewswire/ --   Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated's (NASDAQ: ARAY) newest Synchrony ®  technology on both the CyberKnife ® S7™  and

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.